MedTrace Logo

OCT Angiography in Wet AMD

NCT02253030 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2024-02-12

No results posted yet for this study

Summary

The primary goals of this study are to use optical coherence tomography (OCT) angiography (blood vessel mapping) to:

1. diagnose the presence of new blood vessels in wet age-related macular degeneration (AMD)
2. evaluate patients undergoing treatment for wet AMD
3. determine if reduced flow to the choroid is a risk factor for developing wet AMD.

Conditions

  • Neovascular (Wet) Age-related Macular Degeneration (AMD)

Interventions

DEVICE

Optical Coherence Tomography

Sponsors & Collaborators

  • Oregon Health and Science University

    lead OTHER

Principal Investigators

  • Steven Bailey, MD · Oregon Health and Science University

Eligibility

Min Age
50 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02253030 on ClinicalTrials.gov